GCP
IRON icon

GSA Capital Partners’s Disc Medicine IRON Stock Holding History

GSA Capital Partners’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Buy
+16,324
New +$1.12M 0.08% 396
2026
Q1 		– Sell
-3,287
Closed -$261K – 1938
2025
Q4 		$261K Buy
+3,287
New +$278K 0.02% 1248

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GSA Capital Partners's IRON Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Disc Medicine (IRON) in Q2 2026: 16,324 shares worth $1.19M. The stake represents 0.08% of the portfolio and ranks #396 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in IRON as recently as Q4 2025.

GSA Capital Partners first reported a position in IRON in Q4 2025 and has held it in 2 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • GSA Capital Partners held 16,324 shares of Disc Medicine worth $1.19M as of Q2 2026.
  • Disc Medicine was a new GSA Capital Partners position in Q2 2026.
  • Disc Medicine made up 0.08% of GSA Capital Partners's portfolio in Q2 2026, its #396 holding.
  • GSA Capital Partners first reported a position in Disc Medicine in Q4 2025 and has held it in 2 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.